Shanghai Qilu Pharmaceutical Research Center Co., Ltd agreed to acquire Shanghai Qidu Technology Development Co., Ltd from Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. (SHSE:600895) for approximately CNY 290 million on January 20, 2021. The two parties agree on a one-off payment. Shanghai Qilu Pharmaceutical Research Center Co., Ltd will pay the transaction price other than the deposit to the designated bank account of Shanghai United Assets and Equity Exchange Co., Ltd. on the day when the Shanghai Property Rights Transaction Contract is signed. Shanghai United Assets and Equity Exchange Co., Ltd. will transfer all the transaction price to the bank account designated by Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. within 3 working days after the issue of the equity transaction certificate and the application. The transaction will happen by way of Public Listing. Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. held the 37th Session of the Seventh Board of Directors deliberated and approved the transaction.